The tight link between CRISP3 expression, ERG gene rearrangements and/ or PTEN deletions in the three cohorts of prostate cancer studied, suggest the presence of distinct molecular alterations in this subgroup of tumors that may have additional clinical implication if assessed collectively. Here, PTEN is linked to prostate cancer.